Significant Ownership of DG Capital Management, LLC
- Notable people
- Dov Gertzulin
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for DG Capital Management, LLC focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Dov Gertzulin - Dov Gertzulin, Managing Member
- Manager location
- New York, NY
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow DG Capital Management, LLC with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from DG Capital Management, LLC
Significant Ownership of DG Capital Management, LLC
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| FENC | FENNEC PHARMACEUTICALS INC. | Common Shares | 4.1% | $6,342,597 | 1,114,692 | DG Capital Management, LLC | 31 Dec 2024 | ||
| ATEX | Anterix Inc. | Common Stock, $0.0001 par value | 4% | $15,985,360 | -$4,963,757 | 744,544 | -24% | DG Capital Management, LLC | 30 Sep 2025 |
Schedules 13D/G Reported by DG Capital Management, LLC:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.